From the Nasdaq MarketSite Studio, New to The Street’s TV Host Jane King interviews Nicole Sandford, President, CEO, and Board Member, Michell Snider, Senior Vice-President of Commercial Strategy and Operations, and Lottie Wilder, Market Development Manager of Aspira Women’s Health (NASDAQ: AWH) ($AWH). The Company is transforming gynecologic health by discovering, developing, and commercializing innovative blood-based diagnostic test kits for women with ovarian cancer and other disorders. Nicole updates viewers that the Company completed its clinical study on its OvaWatchSM product for monitoring expansion. Management launched in 2022 the OvaWatch test kit that can monitor and manage women with ovarian adnexal masses. The test provides a single risk assessment score that delivers a negative predictive value of 99% and can advance treatment protocols based on test result outcomes. OvaWatch allows physicians to choose their patients’ clinical management path confidently. Management is focusing on effective commercialization and marketing strategies, looking at a data set to see what is working and not working for AWH to make money. Nicole feels hiring qualified and talented people continues to improve the bottom-line results at AWH. Michell Snider gives her employment history with the Company and discusses a three-point growth strategy: 1) profitability, 2) core physician expansion and retention, and 3) target large-scale partnerships. Lottie Wilder is AWH’s Market Development Manager and shares her personal health experiences. Her family has an ovarian cancer history and has identified that cancer gene in her family tree. With one ovary removed and the other with an adnexal mass, Lottie talks about her experience as a patient with OvaWatch. With a 99.5% personal negative predictive value, Lottie manages her health, accordingly, believing she can enter menopause naturally without removing the other ovary. Nicole sees 2024 as AWH’s year to aggressively market the Company’s products and build upon its proven successes. With the right team, products, and innovations, AWH continues to help women with ovarian cancer and other gynecologic disorders. The on-screen QR code is available during the show to download more info or visit Aspira Women’s Health – https://aspirawh.com/.
To make sure you never miss a video from New to the Street, click here to subscribe: https://www.youtube.com/c/newtothestreettv
Follow New to the Street on Twitter: https://twitter.com/NewToTheStreet
Follow New to the Street on Facebook: https://www.facebook.com/newtothestreet/
Follow New to the Street on Instagram: https://www.instagram.com/newtothestreettv/
Follow New to the Street on Rumble: https://rumble.com/user/newtothestreet
About New to the Street: https://newtothestreet.com/
Subscribe to our Mailing List: https://mailchi.mp/ccd21b3e3fab/join-our-mailing-list